Skip to content
Menu

Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $23

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Wells Fargo analyst James Feldman maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $21 to $23.

Wells Fargo analyst James Feldman maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $21 to $23.

Read at benzinga.com